###begin article-title 0
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DC-SIGNR</italic>
###xml 70 75 <span type="species:ncbi:9606">Child</span>
###xml 92 97 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Functional Genetic Variants in DC-SIGNR Are Associated with Mother-to-Child Transmission of HIV-1
###end article-title 0
###begin p 1
Conceived and designed the experiments: GBL MR. Performed the experiments: GBL ALI. Analyzed the data: GBL MR. Contributed reagents/materials/analysis tools: LSZ JHH AJM BJW MR. Wrote the paper: GBL MR. Lead investigator of this study: MR.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 10 15 <span type="species:ncbi:9606">child</span>
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 76 84 <span type="species:ncbi:9606">children</span>
###xml 331 336 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 435 440 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mother-to-child transmission (MTCT) is the main cause of HIV-1 infection in children worldwide. Given that the C-type lectin receptor, dendritic cell-specific ICAM-grabbing non-integrin-related (DC-SIGNR, also known as CD209L or liver/lymph node-specific ICAM-grabbing non-integrin (L-SIGN)), can interact with pathogens including HIV-1 and is expressed at the maternal-fetal interface, we hypothesized that it could influence MTCT of HIV-1.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 853 861 853 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 157 160 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 188 195 <span type="species:ncbi:9606">infants</span>
###xml 227 234 <span type="species:ncbi:9606">Infants</span>
###xml 374 379 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 452 457 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 782 787 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 880 887 <span type="species:ncbi:9606">infants</span>
###xml 1098 1104 <span type="species:ncbi:9606">infant</span>
To investigate the potential role of DC-SIGNR in MTCT of HIV-1, we carried out a genetic association study of DC-SIGNR in a well-characterized cohort of 197 HIV-infected mothers and their infants recruited in Harare, Zimbabwe. Infants harbouring two copies of DC-SIGNR H1 and/or H3 haplotypes (H1-H1, H1-H3, H3-H3) had a 3.6-fold increased risk of in utero (IU) (P = 0.013) HIV-1 infection and a 5.7-fold increased risk of intrapartum (IP) (P = 0.025) HIV-1 infection after adjusting for a number of maternal factors. The implicated H1 and H3 haplotypes share two single nucleotide polymorphisms (SNPs) in promoter region (p-198A) and intron 2 (int2-180A) that were associated with increased risk of both IU (P = 0.045 and P = 0.003, respectively) and IP (P = 0.025, for int2-180A) HIV-1 infection. The promoter variant reduced transcriptional activity in vitro. In homozygous H1 infants bearing both the p-198A and int2-180A mutations, we observed a 4-fold decrease in the level of placental DC-SIGNR transcripts, disproportionately affecting the expression of membrane-bound isoforms compared to infant noncarriers (P = 0.011).
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
These results suggest that DC-SIGNR plays a crucial role in MTCT of HIV-1 and that impaired placental DC-SIGNR expression increases risk of transmission.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 110 113 110 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Luzuriaga1">[1]</xref>
###xml 698 701 698 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Luzuriaga1">[1]</xref>
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 60 65 <span type="species:ncbi:9606">child</span>
###xml 172 180 <span type="species:ncbi:9606">children</span>
###xml 329 334 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 384 392 <span type="species:ncbi:9606">children</span>
###xml 424 429 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 692 697 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Without specific interventions, the rate of HIV-1 mother-to-child transmission (MTCT) is approximately 15-45% [1]. UNAIDS estimates that last year alone, more than 400,000 children were infected worldwide, mostly through MTCT and 90% of them lived in sub-Saharan Africa. In the most heavily-affected countries, such as Zimbabwe, HIV-1 is responsible for one third of all deaths among children under the age of five. MTCT of HIV-1 can occur during pregnancy (in utero, IU), delivery (intrapartum, IP) or breastfeeding (postpartum, PP). High maternal viral load, low CD4 cells count, vaginal delivery, low gestational age have all been identified as independent factors associated with MTCT of HIV-1 [1]. Although antiretrovirals can reduce MTCT to 2%, limited access to timely diagnostics and drugs in many developing world countries limits the potential impact of this strategy. A better understanding of the mechanisms acting at the maternal-fetal interface is crucial for the design of alternative interventions to antiretroviral therapy for transmission prevention.
###end p 9
###begin p 10
###xml 273 276 273 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Pohlmann1">[2]</xref>
###xml 628 631 628 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Mummidi1">[3]</xref>
###xml 759 762 759 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Pohlmann1">[2]</xref>
###xml 853 856 853 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Chan1">[4]</xref>
###xml 209 214 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 692 697 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Dendritic cell-specific ICAM-grabbing non-integrin-related (DC-SIGNR, also known as CD209L or liver/lymph node-specific ICAM-grabbing non-integrin (L-SIGN)) can interact with a plethora of pathogens including HIV-1 and is expressed in placental capillary endothelial cells [2]. DC-SIGNR is organized in three distinct domains, an N-terminal cytoplasmic tail, a repeat region containing seven repeat of 23 amino acids and a C-terminal domain implicated in pathogen binding. Alternative splicing of DC-SIGNR gene leads to the production of a highly diversify isoforms repertoire which includes membrane-bound and soluble isoforms [3]. It has been proposed that interaction between DC-SIGNR and HIV-1 might enhance viral transfer to other susceptible cell types [2] but DC-SIGNR can also internalize and mediate proteasome-dependant degradation of viruses [4] that may differently affect the outcome of infection.
###end p 10
###begin p 11
###xml 88 93 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 207 212 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 303 306 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 334 341 <span type="species:ncbi:9606">infants</span>
###xml 442 445 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Given the presence of DC-SIGNR at the maternal-fetal interface and its interaction with HIV-1, we hypothesized that it could influence MTCT of HIV-1. To investigate the potential role of DC-SIGNR in MTCT of HIV-1, we carried out a genetic association study of DC-SIGNR in a well-characterized cohort of HIV-infected mothers and their infants recruited in Zimbabwe, and identified specific DC-SIGNR variants associated with increased risks of HIV transmission. We further characterized the functional impact of these genetic variants on DC-SIGNR expression and show that they affect both the level and type of DC-SIGNR transcripts produced in the placenta.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Subjects
###end title 13
###begin p 14
###xml 1678 1681 1678 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Bryson1">[5]</xref>
###xml 2315 2318 2315 2318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Humphrey1">[6]</xref>
###xml 66 71 <span type="species:ncbi:9606">child</span>
###xml 346 351 <span type="species:ncbi:9606">child</span>
###xml 512 517 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 574 579 <span type="species:ncbi:9606">child</span>
###xml 681 686 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 706 711 <span type="species:ncbi:9606">women</span>
###xml 774 781 <span type="species:ncbi:9606">patient</span>
###xml 852 857 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 874 879 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 889 894 <span type="species:ncbi:9606">child</span>
###xml 909 914 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 931 934 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 944 949 <span type="species:ncbi:9606">child</span>
###xml 1040 1047 <span type="species:ncbi:9606">Infants</span>
###xml 1092 1097 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1162 1167 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1233 1240 <span type="species:ncbi:9606">infants</span>
###xml 1412 1417 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1427 1434 <span type="species:ncbi:9606">infants</span>
###xml 1692 1699 <span type="species:ncbi:9606">infants</span>
###xml 1753 1760 <span type="species:ncbi:9606">Infants</span>
###xml 1877 1884 <span type="species:ncbi:9606">Infants</span>
###xml 2097 2102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2112 2119 <span type="species:ncbi:9606">infants</span>
Samples consisted of stored DNA extracts obtained from 197 mother-child pairs co-enrolled immediately postpartum in the ZVITAMBO Vitamin A supplementation trial (Harare, Zimbabwe) and followed at 6 weeks, and 3-monthly intervals up to 24 months. The ZVITAMBO project was a randomized placebo-controlled clinical trial that enrolled 14,110 mother-child pairs, between November 1997 and January 2000, with the main objective of investigating the impact of immediate postpartum vitamin A supplementation on MTCT of HIV-1. The samples used in the present study were from mother-child pairs randomly assigned to the placebo group of the ZVITAMBO project. Antiretroviral prophylaxis for HIV-1-positive antenatal women was not available in the Harare public-sector during ZVITAMBO patient recruitment. The samples were consecutively drawn from two groups: 97 HIV-1-positive mother/HIV-1-positive child pairs and 100 HIV-1-positive mother/HIV-negative child pairs. Mother's serological status was determined by ELISA and confirmed by Western Blot. Infants were considered to be infected if they were HIV-1 seropositive at 18 months or older and had two or more positive HIV-1-DNA polymerase chain reaction (PCR) results at earlier ages. 100 infants were considered to be uninfected as they were ELISA negative at 18 months or older and had two DNA PCR negative results from samples collected at a younger age. Of the 97 HIV-1-infected infants, 57 were infected IU, 11 were infected IP, and 17 were infected PP as determined by PCR analyses of blood samples collected at birth, 6 weeks, 3 and 6 months of age and according to the following definitions adapted from Bryson and colleagues [5]. Briefly, infants who were DNA PCR positive at birth were infected IU. Infants with negative PCR results from sample obtained at birth but who become positive by 6 weeks of age were infected IP. Infants with negative PCR results at birth and 6 weeks of age but who subsequently became DNA PCR positive were considered to be infected during the PP period. In the analysis comparing the 3 different modes of MTCT, 12 HIV-1-infected infants were excluded because the PCR results were not available at 6 weeks of age. Full methods for recruitment, baseline characteristics collection, laboratory procedures have been described elsewhere [6].
###end p 14
###begin title 15
DC-SIGNR haplotypes reconstruction, htSNPs selection and genotyping
###end title 15
###begin p 16
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-BoilyLarouche1">[7]</xref>
###xml 258 261 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Stephens1">[8]</xref>
###xml 495 503 495 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g001">Figure 1</xref>
###xml 594 597 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Zhang1">[9]</xref>
###xml 729 732 727 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-BoilyLarouche1">[7]</xref>
###xml 856 860 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Bashirova1">[10]</xref>
###xml 655 662 <span type="species:ncbi:9606">infants</span>
The nucleotide sequence variation of the entire promoter, coding and part of 3'-UTR regions of DC-SIGNR gene in the study population was determined previously [7]. Haplotype reconstruction was performed using Bayesian statistical method implemented in PHASE [8], version 2.1.1, using single nucleotide polymorphism (SNP) with a minimum allele frequency (MAF) of 2%. We applied the algorithm five times, using different randomly generated seeds, and consistent results were obtained across runs (Figure 1). Fifteen haplotype-tagged SNPs (htSNPs) were identified by the HaploBlockFinder software [9] with a MAF >/=5%. These htSNPs were genotyped in the 197 infants by direct PCR sequencing analysis as we have described previously [7]. The DC-SIGNR exon 4 repeat region genotype was determined by PCR amplification followed by migration in 1.5% agarose gels [10]. DNA sequences in the promoter region were analysed with the TESS interface (http//:) for putative transcription factors binding sites using the TRANSFAC database.
###end p 16
###begin title 17
DC-SIGNR haplotypes reconstruction with minor allele frequency >5% (MAF) and selected htSNPs in Zimbabwean population.
###end title 17
###begin title 18
Luciferase assays
###end title 18
###begin p 19
###xml 749 750 749 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1293 1300 1277 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 670 673 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1125 1128 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Luciferase reporter assays using pGL2-Basic vector were performed in order to investigate the functional effect of mutations on DC-SIGNR promoter activity. Genomic DNA from subjects homozygous for the promoter variants and WT was amplified from nucleotide position -715 to -1 and cloned between the BglII and HindIII multiple cloning sites in the pGL2-Basic vector which harbours a reporter firefly luciferase gene downstream (Invitrogen Canada inc, Burlington, Canada). All recombinants clones were verified by DNA sequencing. The firefly luciferase test reporter vector was co-transfected at a ratio of 10:1 with the constitutive expressor of Renilla luciferase, phRL-CMV (Promega, Madison, WI, USA). We cultured HeLa cells in 6 wells plates (2x105 cells) and transfected them the following day using lipofectamine (Invitrogen) according to the manufacturer. Cells were lysed and luciferase assays were performed using 20 microg of protein extract according to the manufacturer (Promega) at 44 h post-transfection. Firefly luciferase activity was normalized to Renilla luciferase activity. 0 microg, 0,5 microg or 1 microg CMV-Tat vector was transfected with LTR-Luc as a positive control in these experiments. We carried out lucierase assays in triplicate in three independent experiments. Results are expressed as mean+/-standard error of the mean (S.E.M).
###end p 19
###begin title 20
DC-SIGNR isoforms repertoire
###end title 20
###begin p 21
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Liu1">[11]</xref>
###xml 193 198 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
First-term placental tissues were obtained from abortions following voluntary interruption of pregnancy at CHUM Hopital Saint-Luc (Montreal, Canada). Tissues from 3 H1 (associated with MTCT of HIV-1) and 3 H15 (wild-type) homozygous haplotypes were used to analyse possible differences in isoform expression. Total placental RNAs were extracted by MasterPure DNA and RNA Extraction Kit (Epicentre Biotechnologies, Madison, WI, USA) according to the manufacturer. Fragments corresponding to the DC-SIGNR coding region were reversed transcribed (RT) and then amplified by nested PCR with the following primers; RT primers RR, first PCR RF and RR and second PCR RcF and RcR according to Liu and colleagues [11]. 1 microg of total RNA was reverse transcribed with Expand RT (Roche Applied Science, Indianapolis, IN, USA) according to the manufacturer and were PCR-amplified with DNA Platinum Taq Polymerase (Invitrogen). Major PCR products from the second PCR reaction were gel extracted with the Qiagen Gel Extraction Kit (Qiagen Canada inc, Mississauga, ON, Canada) and cloned using the TOPO TA Cloning Kit for sequencing (Invitrogen). For each placenta, 15 different clones were randomly selected and amplified with M13 primers and sequenced with ABI PRISM 3100 capillary automated sequencer (Applied Biosystems, Foster City, CA, USA). Sequences were analysed and aligned with GeneBank reference sequence NM_014257 using Lasergene software (DNA Stars, Madison, WI, USA).
###end p 21
###begin title 22
Quantitative expression of DC-SIGNR isoforms
###end title 22
###begin p 23
###xml 76 78 72 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 624 632 612 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007211.s001">Table S1</xref>
###xml 1655 1662 1643 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">results</xref>
###xml 1710 1711 1698 1699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1950 1957 1938 1945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
1,5 microg of placental RNA was reverse transcribed using 2.5 mM of Oligo dT20 and Expand RT in 20 microl volume according to the manufacturer (Roche Applied Science). 15 ng of total cDNA in a final volume of 20 microl was used to perform quantitative real-time PCR using Universal Express SYBR GreenER qPCR Supermix (Invitrogen) on a Rotor Gene Realtime Rotary Analyser (Corbett Life Science, Sydney, Australia). Samples from 2 subjects in each group were used because RNA quality of others was not suitable for a qRT-PCR analysis. Amplification of all DC-SIGNR isoforms was performed using an exon 5 specific primer pair (Table S1). Membrane-bound isoforms were amplified using primers specific for exon 3, corresponding to the common trans-membrane domain of DC-SIGNR. Primers were targeted to the exon-exon junction and RNA extracts were treated with DNase (Fermantas International inc, Burlington, ON, Canada) to avoid amplification of contaminant DNA. Standard curves (50-500 000 copies per reaction) were generated using serial dilution of a full-length DC-SIGNR or commercial GAPDH (Invitrogen) plasmid DNA. All qPCR reactions had efficiencies ranging from 99% to 100%, even in the presence of 20 ng of non-specific nucleic acids, and therefore could be compared. The copy number of unknown samples was estimated by placing the measured PCR cycle number (crossing threshold) on the standard curve. To correct for differences in both RNA quality and quantity between samples, the expression levels of transcripts were normalised to the reference GAPDH gene transcripts. GAPDH primer sequences were kindly provided by A. Mes-Masson at the CHUM. The results are presented as target gene copy number per 105 copies of GAPDH. The ratio of membrane-bound isoforms was calculated as E3/E5. Soluble isoforms were calculated by subtracting membrane-bound from total isoforms. We carried out qPCR assays in triplicate in three independent experiments. Results are expressed as mean+/-S.E.M.
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 253 254 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 695 696 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Statistical analysis was performed using the GraphPad PRISM 5.0 for Windows (GraphPad Software inc, San Diego, CA, USA). Differences in baseline characteristics and genotypic frequencies of haplotypes or htSNPs were compared between groups using the chi2 analysis or Fisher's exact test. Logistic regression analysis was used to estimate odds ratios (OR) for each genotype and baseline risk factors. Multiple logistic regression was used to define independent predictors identified as significant in the crude analysis. ORs and 95% confidence interval were calculated with the exact method. Comparisons of continuous variables between groups were assessed with the unpaired two-tailed Student's t test when variables were normally distributed and with the Mann-Whitney U test when otherwise. Differences were considered significant at P<0.05.
###end p 25
###begin title 26
Ethics statement
###end title 26
###begin p 27
###xml 322 327 <span type="species:ncbi:9606">Human</span>
Written informed consent was obtained from all mothers who participated in the study and the ZVITAMBO trial and the investigation reported in this paper were approved by The Medical Research Council of Zimbabwe, The Medicines Control Authority of Zimbabwe, The Johns Hopkins Bloomberg School of Public Health Committee on Human Research, and the CHUM and Montreal General Hospital Ethics Committees. First-term placental tissues were obtained from abortions following voluntary interruption of pregnancy at CHUM Hopital Saint-Luc (Montreal, Canada) with written informed consent in accordance with the CHUM Research Ethics Committee.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 464 471 464 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007211-t001">Table 1</xref>
###xml 68 75 <span type="species:ncbi:9606">infants</span>
###xml 94 99 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 163 170 <span type="species:ncbi:9606">infants</span>
###xml 176 181 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 199 206 <span type="species:ncbi:9606">infants</span>
###xml 238 243 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 253 260 <span type="species:ncbi:9606">infants</span>
###xml 375 380 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 390 397 <span type="species:ncbi:9606">infants</span>
###xml 439 446 <span type="species:ncbi:9606">infants</span>
###xml 506 511 <span type="species:ncbi:9606">child</span>
###xml 824 829 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We carried out an association study of DC-SIGNR polymorphism in 197 infants born to untreated HIV-1-infected mothers recruited in Harare, Zimbabwe. Among them, 97 infants were HIV-1-infected and 100 infants remained uninfected. Of the 97 HIV-1-infected infants, 57 were infected IU, 11 were infected IP, and 17 were infected PP. Timing of infection was not determined for 12 HIV-1-infected infants. Baseline characteristics of mothers and infants are presented in Table 1. Maternal age and CD4 cell count, child sex, mode of delivery, duration of membrane rupture and gestational age were similar among all groups. However, maternal viral load >29 000 copies/ml was associated with increased risk in both IU and PP with odds ratios (OR) of 3.64 (95% CI = 1.82-7.31, P = 0.0002) and 4.45 (95% CI = 1.50-13.2, P = 0.0045) for HIV-1 transmission, respectively.
###end p 29
###begin title 30
###xml 39 46 <span type="species:ncbi:9606">infants</span>
###xml 130 135 <span type="species:ncbi:9606">child</span>
###xml 136 141 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Baseline characteristics of mother and infants risk factors for intrauterine (IU), intrapartum (IP) and postpartum (PP) mother-to-child HIV-1 transmission.
###end title 30
###begin p 31
CI, Confidence interval; F, female; M, male; N, number; OR, odds ratio; SD, standard deviation.
###end p 31
###begin p 32
P value as determined by Mann-Whitney U test.
###end p 32
###begin p 33
P value as determined by the Fisher's exact test.
###end p 33
###begin p 34
###xml 32 33 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
P value as determined by the chi2 test.
###end p 34
###begin p 35
###xml 90 98 90 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g001">Figure 1</xref>
###xml 128 131 128 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-BoilyLarouche1">[7]</xref>
###xml 169 178 169 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007211.s002">Tables S2</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007211.s003">S3</xref>
###xml 254 262 254 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g001">Figure 1</xref>
###xml 420 427 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007211-t002">Table 2</xref>
###xml 669 676 669 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007211-t002">Table 2</xref>
###xml 1004 1012 1004 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g001">Figure 1</xref>
###xml 1109 1117 1109 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007211.s002">Table S2</xref>
###xml 1426 1433 1426 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007211-t003">Table 3</xref>
###xml 400 405 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 430 437 <span type="species:ncbi:9606">Infants</span>
###xml 621 626 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 649 655 <span type="species:ncbi:9606">infant</span>
###xml 881 886 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1102 1107 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1170 1177 <span type="species:ncbi:9606">infants</span>
###xml 1361 1366 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1402 1409 <span type="species:ncbi:9606">infants</span>
###xml 1651 1656 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1677 1684 <span type="species:ncbi:9606">infants</span>
###xml 1813 1818 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Fifteen haplotype-tagged SNPs (htSNPs) corresponding to the 15 major DC-SIGNR haplotypes (Figure 1) described among Zimbabweans [7] were genotyped in our study samples (Tables S2 and S3). H1 (31%) and H3 (11%) were the most frequent haplotypes observed (Figure 1). Being homozygous for the H1 haplotype was associated with increased risk of both IU (OR: 4.42, P = 0.022) and PP (OR: 7.31, P = 0.016) HIV-1 transmission (Table 2). Infants harbouring two copy combinations of H1 and/or H3 haplotypes (H1-H1, H1-H3 or H3-H3) had increased risk of IU (OR: 3.42, P = 0.007) and IP (OR: 5.71, P = 0.025) but not PP (P = 0.098) HIV-1 infection compared to infant noncarriers (Table 2). The latter associations remained significant after adjustment was made for the maternal viral load for both IU (OR: 3.57, 95% CI = 1.30-9.82, P = 0.013) and IP (OR: 5.71, 95% CI = 1.40-23.3, P = 0.025) HIV-1 transmission. The H1 and H3 haplotypes share a cluster of mutations (p-198A, int2-391C, int2-180A, ex4RPT, int5+7C) (Figure 1). Of these, the p-198A and int2-180A variants were significantly associated with MTCT of HIV-1 (Table S2). In the unadjusted regression analysis, homozygous infants for the p-198A and int2-180A variants had increased risk of IU (OR: 2.07 P = 0.045, OR: 3.78, P = 0.003, respectively) and IP (OR: 2.47, P = 0.17, O.R: 5.71, P = 0.025, respectively) HIV-1 infection compared to heterozygote infants or noncarriers (Table 3). When adjustment was made for maternal factors, only the association with the int2-180A variant remained significant for IU (OR: 3.83, 95% CI = 1.42-10.4, P = 0.008) and IP (O.R: 5.71, 95% CI = 1.40-23.3, P = 0.025) HIV-1 transmission. Thus, infants homozygous for DC-SIGNR variant int2-180A contained in H1 and H3 haplotypes were 4-fold to 6-fold more likely to be infected by HIV-1 during pregnancy or at delivery, respectively.
###end p 35
###begin title 36
###xml 21 27 <span type="species:ncbi:9606">infant</span>
###xml 118 123 <span type="species:ncbi:9606">child</span>
###xml 124 129 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Associations between infant DC-SIGNR haplotypes and intrauterine (IU), intrapartum (IP) and postpartum (PP) mother-to-child HIV-1 transmission.
###end title 36
###begin p 37
CI, Confidence interval; N, number; NA, not applicable; OR, odds ratio.
###end p 37
###begin p 38
P value as determined by the Fisher's exact test.
###end p 38
###begin p 39
###xml 32 33 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
P value as determined by the chi2 test.
###end p 39
###begin title 40
###xml 21 27 <span type="species:ncbi:9606">infant</span>
###xml 155 160 <span type="species:ncbi:9606">child</span>
###xml 161 166 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Associations between infant DC-SIGNR promoter p-198 and intron 2 (int2)-180 variants and intrauterine (IU), intrapartum (IP) and postpartum (PP) mother-to-child HIV-1 transmission.
###end title 40
###begin p 41
CI, Confidence interval; N, number; OR, odds ratio.
###end p 41
###begin p 42
P value as determined by the Fisher's exact test.
###end p 42
###begin p 43
###xml 32 33 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
P value as determined by the chi2 test.
###end p 43
###begin p 44
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DC-SIGNR</italic>
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Mummidi1">[3]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Liu1">[11]</xref>
###xml 1038 1047 1038 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007211.s004">Figure S1</xref>
###xml 1511 1514 1511 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Mummidi1">[3]</xref>
###xml 1686 1695 1686 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007211.s004">Figure S1</xref>
###xml 2008 2017 2008 2017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g002">Figure 2A</xref>
###xml 2661 2670 2661 2670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g002">Figure 2B</xref>
###xml 235 240 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 335 340 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 706 711 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1864 1871 <span type="species:ncbi:9606">infants</span>
###xml 2268 2275 <span type="species:ncbi:9606">infants</span>
###xml 2525 2532 <span type="species:ncbi:9606">infants</span>
###xml 2798 2803 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Alternative splicing of the DC-SIGNR gene in the placenta produces both membrane-bound and soluble isoform repertoires [3]. The relative proportion of membrane bound and soluble DC-SIGNR could plausibly influence the susceptibility to HIV-1 infection [11]. We therefore hypothesized that the DC-SIGNR mutations associated with MTCT of HIV-1 would have an impact on both the level of DC-SIGNR expression and in the isoform repertoire produced. We investigated DC-SIGNR transcript expression in first-term placentas obtained after elective abortion. We cloned DC-SIGNR from placental tissues by RT-PCR from 3 homozygous H1 samples containing both the DC-SIGNR p-198AA and int2-180AA variants associated with HIV-1 transmission and 3 homozygous wild-type (WT) (p-198CC, int2-180GG) samples. Fifteen clones per sample were randomly selected for sequencing. As expected, we found an extensive repertoire of DC-SIGNR transcripts in all samples with 9 to 16 different isoforms per individual. A total of 65 distinct transcripts were identified (Figure S1), of which 3 were full-length transcripts. 64 of the sequenced clones contained a total of 69 amino acid substitutions with 3 new C termini and 2 premature stop codons. However, the diversity was mostly attributable to the entire deletion of exon 2 or exon 3 or to variations in the length of the neck region (exon 4) of DC-SIGNR. The deletion of exon 3 eliminates the trans-membrane domain of the protein and leads to the expression of soluble DC-SIGNR isoforms [3]. Interestingly, the abundance of membrane-bound isoforms in placental tissues of the H1 homozygotes appears to be lower than that observed in samples from WT individuals (Figure S1). The deletion of exon 3 was confirmed by sequencing and we hypothesize that the skipping of exon 3, could be due to the presence of the int2-180A mutation observed in infants with the H1 haplotype. In fact, this intron mutation is located 180 bp downstream from exon 3 and potentially modifies splicing events (Figure 2A). We confirmed that the variation in transcript proportions seen between the two groups was also reflected at the level of mRNA expression in the placenta. To quantify membrane-bound vs soluble isoforms in placental samples from homozygous H1 and WT infants, we amplified the exon 5 (E5) sequence present in all DC-SIGNR isoforms (total transcripts). We then amplified exon 3 (E3) which is deleted in the soluble forms and then calculated the E3:E5 ratio. We found that placental tissues from homozygous H1 infants express a significantly lower proportion of membrane-bound DC-SIGNR (18%) compared to that in WT individuals (36%) (P = 0.004) (Figure 2B) suggesting that exon 3 skipping happens more frequently in presence of the DC-SIGNR int2-180A variant associated with MTCT of HIV-1.
###end p 44
###begin title 45
Effect of the int2-180A variant on placental DC-SIGNR isoform expression.
###end title 45
###begin p 46
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DC-SIGNR</italic>
###xml 480 481 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
(a) Schematic representation of the int2-180A variant location within the DC-SIGNR gene. (b) Proportion of DC-SIGNR membrane-bound and soluble isoforms in homozygous H1 (int2-180AA) and homozygous WT (int2-180GG) placental samples estimated by qRT-PCR assays in three independent experiments performed in triplicate. Data are presented as percentage of total transcripts. Differences between isoform proportions among the homozygous H1 and homozygous WT were calculated by the chi2 test.
###end p 46
###begin p 47
###xml 88 96 88 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g001">Figure 1</xref>
###xml 237 244 237 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007211-t003">Table 3</xref>
###xml 607 615 607 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DC-SIGNR</italic>
###xml 685 694 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g003">Figure 3A</xref>
###xml 856 865 856 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g003">Figure 3B</xref>
###xml 1064 1073 1064 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007211.s005">Figure S2</xref>
###xml 1438 1439 1434 1435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1608 1617 1602 1611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g003">Figure 3C</xref>
###xml 2231 2240 2217 2226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g003">Figure 3C</xref>
###xml 217 222 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1498 1505 <span type="species:ncbi:9606">infants</span>
###xml 2318 2323 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The DC-SIGNR int2-180A variant is always transmitted with the promoter mutation p-198A (Figure 1). In the unadjusted regression analysis, the p-198A variant was significantly associated with IU but not with IP and PP HIV-1 transmission (Table 3). Computational transcription factor binding site analysis predicts that this mutation, located 198 bp upstream of the start codon would affect a C/EBPbeta transcription factor binding site (TESS web site). To test the effect of DC-SIGNR p-198A variant on transcription, we transiently transfected HeLa cells with a luciferase reporter gene under the control of DC-SIGNR promoter region -715 to -1 with either C (WT) or A at position -198 (Figure 3A). The luciferase activity of the p-198A variant construct was significantly lower than that of the WT p-198C promoter construct (p-198C/A ratio = 2, P = 0.006) (Figure 3B) suggesting that DC-SIGNR p-198A affects promoter activity. The other promoter mutants (p-577C and p-323A) observed in the Zimbabwean population did not affect DC-SIGNR transcription in this assay (Figure S2). To determine the net impact of the DC-SIGNR p-198A mutation on DC-SIGNR expression in the placenta, we quantitated the absolute number of total and membrane-bound DC-SIGNR transcripts in the H1 homozygote and wild-type placental samples as described earlier. The total number of DC-SIGNR transcripts was determined to be 685+/-213 (DC-SIGNR copies+/-S.E.M per 105 GAPDH copies) in the placental samples from homozygous H1 infants and was 4-fold lower compared to that found in placentas from WT individuals (2781+/-638, P = 0.011) (Figure 3C). As suggested earlier, the int2-180A mutation might induce exon 3 skipping leading to a lower production of membrane-bound DC-SIGNR. Although, the decrease in the total number of DC-SIGNR transcripts in H1 homozygous placental samples containing both the p-198AA and int2-180AA variants affected the proportion of membrane-bound and soluble isoforms, the effect of these mutations was more pronounced on the membrane-bound isoforms with an 8-fold decrease (H1 = 117+/-36.2 vs WT = 990+/-220.6, P = 0.003) compared to a 3-fold decrease in total soluble isoforms (H1 = 568+/-181.9 vs WT = 1925+/-495.3, P = 0.03) (Figure 3C). Therefore, DC-SIGNR p-198A and int2-180A mutations associated with MTCT of HIV-1 significantly decreased the level of total placental DC-SIGNR transcripts, disproportionately affecting the membrane-bound isoform production.
###end p 47
###begin title 48
Transcriptional activity of DC-SIGNR promoters.
###end title 48
###begin p 49
###xml 93 101 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 691 692 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 981 982 977 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1017 1018 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(a, b) Effect of the p-198A variant on transcriptional activity in luciferase reporter assay in vitro in transfected HeLa cells. (a) Schematic representation of reporter gene constructs corresponding to the DC-SIGNR promoter region from -715 to -1, spanning with either C (WT) or A at position -198. (b) Relative luciferase expression from pGL2-Basic, the parental vector without the promoter. Expression of the DC-SIGNR promoter constructs were calculated relatively to this value. Data are presented in mean+/-S.E.M. values of three independent experiments performed in triplicate and difference in relative luciferase expression between the p-198 variants was examined with the Student's t test. (c) Total number of DC-SIGNR isoforms in homozygous H1 (p-198AA, int2-180AA) and homozygous WT (p-198CC, int2-180GG) placental samples measured by qRT-PCR assays in three independent experiments performed in triplicate. Data are shown in mean+/-S.E.M. copies number normalized by 105 copies number of GAPDH. Student's t test was used to calculate differences in the number of isoforms between the H1 and WT groups.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 520 528 520 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g001">Figure 1</xref>
###xml 1167 1175 1167 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1451 1459 1451 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007211-g001">Figure 1</xref>
###xml 1534 1541 1534 1541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 111 116 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 371 378 <span type="species:ncbi:9606">infants</span>
###xml 682 687 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 788 793 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1702 1707 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our genetic results, supported by expression assay in placenta, suggest the involvement of DC-SIGNR in MTCT of HIV-1. Homozygosity for the haplotype H1 was associated with IU transmission in the unadjusted regression analysis. However, the association disappeared after adjustment was made for the maternal factors presumably because of the small number of H1 homozygote infants analysed in each groups. H1 and H3 were the most frequent haplotypes observed in the study population and they share a cluster of mutations (Figure 1). Grouping haplotypes H1 and H3 increased the power of the study and permitted the identification of specific DC-SIGNR mutations associated with MTCT of HIV-1. Indeed, two mutations shared by haplotypes H1 and H3 were associated with vertical transmission of HIV-1. The int2-180A was associated with a 4-fold increased risk of IU and 6-fold increased risk of IP after adjustment for the maternal factors. Although the p-198A variant was associated with IU transmission, the association disappeared after adjustment was made for the maternal viral load. Nevertheless, we showed that this mutation reduces DC-SIGNR transcriptional activity in vitro and produces lower level of DC-SIGNR transcripts in placental tissues in combination with the int2-180A variant. Since int2-180A is always transmitted with p-198A on the MTCT associated combined haplotypes H1/H3, whereas p-198A is carried on other non-associated haplotypes (Figure 1), we can speculate that the p-198A mutation alone may have a minor effect in vivo whereas in combination with the int2-180A variant, they both act to reduce the level of placental DC-SIGNR expression resulting in an increased risk of MTCT of HIV-1.
###end p 51
###begin p 52
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Kourtis1">[12]</xref>
###xml 446 449 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Mummidi1">[3]</xref>
###xml 825 832 <span type="species:ncbi:9606">infants</span>
The majority of IU transmission occurs during the last trimester of pregnancy (reviewed in [12]). Full-term placenta samples were not available for the current study and the expression assays were performed on first-term placental tissues. A previous study looking at DC-SIGNR placental isoforms repertoire in full-term placenta samples demonstrated similar diversity of DC-SIGNR transcripts as in the first-term placental tissues studied herein [3]. However, since levels of DC-SIGNR expression have never been compared between the different terms of pregnancy, it is not known whether DC-SIGNR expression varies during the course of pregnancy. Nevertheless, it is reasonable to assume that the inter-individual differences in both DC-SIGNR isoform repertoire and transcript levels observed between the H1 and WT homozygous infants would be reflected throughout the pregnancy.
###end p 52
###begin p 53
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 105 108 105 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Pohlmann1">[2]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Bashirova1">[10]</xref>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 316 323 316 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Wiley1">[13]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Turville1">[14]</xref>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Snyder1">[15]</xref>
###xml 878 881 878 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Chan1">[4]</xref>
###xml 1031 1035 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Limmer1">[16]</xref>
###xml 1037 1041 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Pober1">[17]</xref>
###xml 1175 1179 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Soilleux1">[18]</xref>
###xml 1181 1185 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Mukhtar1">[19]</xref>
###xml 1337 1341 1337 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Kanmogne1">[20]</xref>
###xml 1343 1347 1343 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Yang1">[21]</xref>
###xml 91 96 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 386 391 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 588 593 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 654 659 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1047 1052 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1187 1192 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1502 1507 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1603 1608 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1685 1690 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To date, most studies have focused on the potential role of DC-SIGNR in trans infection of HIV-1 in vitro[2], [10]. However, the multiple mechanisms involved in trans infection and redundancy among C-type lectin functions make it difficult to determine the actual participation of DC-SIGNR in this mode of infection in vivo[13], [14]. The strong correlation we observed between MTCT of HIV-1 and DC-SIGNR genetic variants producing low levels of DC-SIGNR in the placenta suggested that mechanisms other than DC-SIGNR-mediated trans infection might operate during vertical transmission of HIV-1. For example, DC-SIGNR has also been shown to function as a HIV-1 antigen-capturing receptor [15]. Chan and colleagues recently demonstrated that DC-SIGNR transfected CHO cells diminish SARS-CoV titers by enhanced capture and degradation of the virus in a proteasome-dependent manner [4]. Since endothelial cells express MHC-I and II, degraded viral antigens could then be presented to immune cells to elicit an adaptive immune response [16], [17]. The HIV-1 co-receptor CCR5, but not CD4, is co-expressed with DC-SIGNR on placental and blood-brain barrier (BBB) endothelial cells [18], [19]. HIV-1 gp120 binding to CCR5 receptor on endothelial cells compromises BBB integrity and enhances monocytes adhesion and transmigration across the BBB [20], [21]. It is thus possible that reduced expression of DC-SIGNR, particularly the membrane-bound isoforms, on placental capillary endothelial cells might favour HIV-1 binding to CCR5 receptor, instead of DC-SIGNR receptor, facilitating the migration of maternal HIV-1-infected cells across the placental barrier resulting in IU transmission of HIV-1.
###end p 53
###begin p 54
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Kwiek1">[22]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Kwiek2">[23]</xref>
###xml 933 937 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Kwiek1">[22]</xref>
###xml 149 154 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 236 241 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 316 323 <span type="species:ncbi:9606">infants</span>
###xml 522 527 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 820 825 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1077 1084 <span type="species:ncbi:9606">infants</span>
###xml 1132 1137 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The int2-180A variant contained in the H1 and H3 haplotypes was associated with IP transmission suggesting that DC-SIGNR also affect transmission of HIV-1 during delivery. Little is known about the mechanisms underlying transmission of HIV-1 during delivery. Passage through the birth canal could potentially expose infants through a mucosal portal entry (presumably ophthalmic, skin, or gastrointestinal), whereas placental insult during delivery (physical or inflammatory) may enhance transplacental passage of maternal HIV-1-infected cells into foetal circulation [22], [23]. Such process called microtransfusion has been proposed in regards to the results obtain in a Malawian cohort. Kweik and colleagues found a significant association between levels of maternal DNA in umbilical cord blood and IP transmission of HIV-1 suggesting that passage of maternal infected cells through the placenta is likely to occur during delivery [22]. Thus, in a similar fashion as suggested earlier for IU transmission, the relatively lower level of DC-SIGNR in the placenta of homozygous infants harbouring the int2-180A variant could promote HIV-1 binding to CCR5 receptor on endothelial cells affecting the placental barrier integrity and facilitating the passage of maternal infected cells in foetal circulation during delivery.
###end p 54
###begin p 55
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Singh1">[24]</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Pedersen1">[25]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Singh2">[26]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Singh3">[27]</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Martinson1">[28]</xref>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Kuhn1">[29]</xref>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-MeddowsTaylor1">[30]</xref>
###xml 1082 1086 1082 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Mangano1">[31]</xref>
###xml 1088 1092 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007211-Boniotto1">[32]</xref>
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 175 180 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 299 304 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 438 443 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 557 562 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 666 671 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 692 699 <span type="species:ncbi:9606">infants</span>
###xml 1076 1081 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Beside DC-SIGNR, other HIV-1 receptors are known to influence MTCT of HIV-1 (reviewed in [24]). Genetic variants in CCR5 have been shown to influence vertical transmission of HIV-1. CCR5 promoter variants resulting in higher expression of the receptor were associated with increased risk of MTCT of HIV-1 among sub-Saharan Africans [25], [26]. The 32-pb deletion polymorphism in CCR5 has be shown to protect from vertical transmission of HIV-1 [27], but this variant is virtually absent among African populations [28]. High copy numbers of CCL3L1, a potent HIV-1 suppressive ligand for CCR5, are associated with higher chemokine production and lower risk of MTCT of HIV-1 among South African infants [29], [30]. Mannose-binding lectin (MBL) is an innate immune receptor synthesised in the liver and secreted in the bloodstream in response to inflammation signal. MBL promotes pathogen elimination by opsonization and phagocytosis, and reduced expression of MBL resulting from polymorphism in coding and non-coding regions has been associated with an increased risk of MTCT of HIV-1 [31], [32].
###end p 55
###begin p 56
###xml 170 175 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 272 279 <span type="species:ncbi:9606">infants</span>
###xml 285 290 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 420 425 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 563 568 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 625 630 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 744 749 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 751 762 <span type="species:ncbi:11103">hepatitis C</span>
In this study, we demonstrate for the first time, the potential functional impact of DC-SIGNR mutations on its expression in the placenta and in vertical transmission of HIV-1. We believe that the presence of DC-SIGNR at the placental endothelial cell surface may protect infants from HIV-1 infection by capturing virus and promoting its degradation/presentation. However, in placenta containing low levels of DC-SIGNR, HIV-1 would preferentially binds CCR5 on endothelial cells resulting in a loss of placental barrier integrity and enhanced passage of maternal HIV-1-infected cells in foetal circulation leading to MTCT of HIV-1. This mechanism may also apply to other vertically-transmitted pathogens known to interact with DC-SIGNR such as HIV-2, hepatitis C and dengue viruses and warrant further investigation.
###end p 56
###begin title 57
Supporting Information
###end title 57
###begin p 58
Primer pairs and qRT-PCR conditions for DC-SIGNR expression assays. a Accession number NM_014257, b Accession number NM_002046
###end p 58
###begin p 59
(0.03 MB DOC)
###end p 59
###begin p 60
Click here for additional data file.
###end p 60
###begin p 61
###xml 21 26 <span type="species:ncbi:9606">child</span>
###xml 57 62 <span type="species:ncbi:9606">child</span>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Associations between child DC-SIGNR htSNPs and mother-to-child HIV-1 transmission. CI, Confidence interval; htSNPs, haplotypes-tagged single nucleotide polymorphisms; N, number; OR, odds ratio, NA; not applicable, Del; deletion. a P-value as determined by the Chi-square test.
###end p 61
###begin p 62
(0.09 MB DOC)
###end p 62
###begin p 63
Click here for additional data file.
###end p 63
###begin p 64
###xml 21 26 <span type="species:ncbi:9606">child</span>
###xml 83 88 <span type="species:ncbi:9606">child</span>
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Associations between child DC-SIGNR exon 4 repeated region genotypes and mother-to-child HIV-1 transmission.CI, Confidence interval; N, number; NA; not applicable; OR, odds ratio a P-value as determined by the Chi-square test. b Comparison between genotype and all others.
###end p 64
###begin p 65
(0.05 MB DOC)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
DC-SIGNR transcripts repertoire in placenta. Major RT-PCR products from RNA extract from 3 homozygous H1 and 3 homozygous WT placenta samples were purified, cloned and sequenced. Sequenced were analysed according to NCBI reference sequence NM_014257. CT; cytoplasmic tail, TM; trans-membrane domain; WT; wild-type
###end p 67
###begin p 68
(0.11 MB DOC)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
###xml 695 698 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Effect of DC-SIGNR promoter variant on transcriptional activity in luciferase reporter assay in vitro in transfected HeLa cells. Relative luciferase expression from pGL2-Basic, parental vector without promoter. Expression DC-SIGNR promoter constructs, spanning p-577C variant or p-323A variant were calculated relatively to this value. Data are presented in mean values+/-S.E.M of three independent experiments performed in triplicate. One-way ANOVA test followed by the Dunnett test for multiple comparison was used to compare the relative luciferase expression of the p-557C and p-323A variant reporters against the wild-type (WT) construct (not significant). 0 microg, 0,5 microg or 1 microg CMV-Tat vector was transfected with LTR-Luc as a positive control in these experiments.
###end p 70
###begin p 71
(0.27 MB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
###xml 163 175 <span type="species:ncbi:9606">participants</span>
The authors would like to thank to G Roy and F Leger of the CHUM for providing the placenta samples, M Milev and L Ajamian for technical assistance and all of the participants in this study and the ZVITAMBO Study Group: H Chidawanyika, P Iliff, A Mahomva, F Majo, L Malaba, M Mbizvo, L Moulton, K Mutasa, J Mutsambi, K Nathoo, M Ndhlovu, L Propper, A Ruff, N Tavengwa, C Zunguza, P Zvandasara.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
###xml 10 15 <span type="species:ncbi:9606">child</span>
###xml 32 35 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Mother-to-child Transmission of HIV: A Global Perspective.
###end article-title 75
###begin article-title 76
###xml 71 76 <span type="species:ncbi:9606">human</span>
DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans.
###end article-title 76
###begin article-title 77
Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts.
###end article-title 77
###begin article-title 78
###xml 54 70 <span type="species:ncbi:227859">SARS coronavirus</span>
Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection.
###end article-title 78
###begin article-title 79
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Proposed definitions for in utero versus intrapartum transmission of HIV-1.
###end article-title 79
###begin article-title 80
###xml 83 86 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 96 101 <span type="species:ncbi:9606">women</span>
###xml 112 119 <span type="species:ncbi:9606">infants</span>
###xml 124 129 <span type="species:ncbi:9606">child</span>
###xml 130 133 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 145 148 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality.
###end article-title 80
###begin article-title 81
DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: Potential implications for pathogen recognition and disease susceptibility.
###end article-title 81
###begin article-title 82
A new statistical method for haplotype reconstruction from population data.
###end article-title 82
###begin article-title 83
HaploBlockFinder: haplotype block analyses.
###end article-title 83
###begin article-title 84
###xml 130 135 <span type="species:ncbi:9606">human</span>
###xml 184 189 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection.
###end article-title 84
###begin article-title 85
###xml 37 40 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms.
###end article-title 85
###begin article-title 86
###xml 10 15 <span type="species:ncbi:9606">child</span>
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mother-to-child transmission of HIV-1: timing and implications for prevention.
###end article-title 86
###begin article-title 87
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection.
###end article-title 87
###begin article-title 88
###xml 31 34 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Diversity of receptors binding HIV on dendritic cell subsets.
###end article-title 88
###begin article-title 89
###xml 47 82 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.
###end article-title 89
###begin article-title 90
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance.
###end article-title 90
###begin article-title 91
Evolving functions of endothelial cells in inflammation.
###end article-title 91
###begin article-title 92
###xml 14 42 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 44 47 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 91 94 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Expression of human immunodeficiency virus (HIV)-binding lectin DC-SIGNR: Consequences for HIV infection and immunity.
###end article-title 92
###begin article-title 93
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 77 80 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 81 84 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN.
###end article-title 93
###begin article-title 94
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.
###end article-title 94
###begin article-title 95
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling.
###end article-title 95
###begin article-title 96
###xml 70 75 <span type="species:ncbi:9606">child</span>
###xml 92 97 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Maternal-fetal DNA admixture is associated with intrapartum mother-to-child transmission of HIV-1 in Blantyre, Malawi.
###end article-title 96
###begin article-title 97
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 53 58 <span type="species:ncbi:9606">child</span>
Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi.
###end article-title 97
###begin article-title 98
###xml 29 32 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 70 78 <span type="species:ncbi:9606">Children</span>
Host Genetic Determinants of HIV Infection and Disease Progression in Children.
###end article-title 98
###begin article-title 99
###xml 30 35 <span type="species:ncbi:9606">child</span>
###xml 36 39 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CCR5 haplotypes and mother-to-child HIV transmission in Malawi.
###end article-title 99
###begin article-title 100
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 70 75 <span type="species:ncbi:9606">child</span>
Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.
###end article-title 100
###begin article-title 101
###xml 54 84 <span type="species:ncbi:11676">human immunodeficiency virus 1</span>
###xml 86 91 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 153 161 <span type="species:ncbi:9606">children</span>
###xml 179 184 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
###end article-title 101
###begin article-title 102
Global distribution of the CCR5 gene 32-basepair deletion.
###end article-title 102
###begin article-title 103
###xml 8 15 <span type="species:ncbi:9606">infants</span>
###xml 54 57 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine.
###end article-title 103
###begin article-title 104
###xml 101 131 <span type="species:ncbi:11676">human immunodeficiency virus 1</span>
Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission.
###end article-title 104
###begin article-title 105
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Detrimental effects of mannose-binding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression.
###end article-title 105
###begin article-title 106
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression.
###end article-title 106
###begin p 107
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: J. H. received an operating grant from BASF for the ZVITAMBO project.
###end p 107
###begin p 108
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: G.B.-L. holds a Doctoral Research Award from the Canadian Institute of Health Research (CIHR) and M.R. and A.J.M. are supported by career awards from the Fonds de la Recherche en Sante du Quebec (FRSQ). This work was supported by a grant from Reseau SIDA Fonds de la Recherche en Sante du Quebec (FRSQ) to M.R. and a grant from the CIHR to A.J.M. The ZVITAMBO project was supported by the Canadian International Development Agency (CIDA) (R/C Project 690/M3688), United States Agency for International Development (USAID) (cooperative agreement number HRN-A-00-97-00015-00 between Johns Hopkins University and the Office of Health and Nutrition - USAID) and a grant from the Bill and Melinda Gates Foundation, Seattle, WA. Additional funding was received from the Rockefeller Foundation (NY, NY) and BASF (Ludwigshafen Germany). It is a collaborative project of the University of Zimbabwe, the Harare City Health Department, the Johns Hopkins Bloomberg School of Public Health, and the Research Institute of McGill University Health Centres. J.H. received an operating grant from BASF for the ZVITAMBO project. The BASF and other funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 108

